Shattuck Labs Inc
NASDAQ:STTK
Intrinsic Value
Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. [ Read More ]
The intrinsic value of one STTK stock under the Base Case scenario is 0.63 USD. Compared to the current market price of 9.9 USD, Shattuck Labs Inc is Overvalued by 94%.
Valuation Backtest
Shattuck Labs Inc
Run backtest to discover the historical profit from buying and selling STTK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shattuck Labs Inc
Current Assets | 143.2m |
Cash & Short-Term Investments | 130.6m |
Other Current Assets | 12.6m |
Non-Current Assets | 16.3m |
PP&E | 16.1m |
Other Non-Current Assets | 269k |
Current Liabilities | 11.5m |
Accounts Payable | 1.6m |
Accrued Liabilities | 9.9m |
Non-Current Liabilities | 3.4m |
Other Non-Current Liabilities | 3.4m |
Earnings Waterfall
Shattuck Labs Inc
Revenue
|
1.7m
USD
|
Operating Expenses
|
-93.3m
USD
|
Operating Income
|
-91.7m
USD
|
Other Expenses
|
4.4m
USD
|
Net Income
|
-87.3m
USD
|
Free Cash Flow Analysis
Shattuck Labs Inc
STTK Profitability Score
Profitability Due Diligence
Shattuck Labs Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Shattuck Labs Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
STTK Solvency Score
Solvency Due Diligence
Shattuck Labs Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Shattuck Labs Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STTK Price Targets Summary
Shattuck Labs Inc
According to Wall Street analysts, the average 1-year price target for STTK is 11.9 USD with a low forecast of 11.11 USD and a high forecast of 12.6 USD.
Ownership
STTK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
STTK Price
Shattuck Labs Inc
Average Annual Return | 4.28% |
Standard Deviation of Annual Returns | 139.25% |
Max Drawdown | -98% |
Market Capitalization | 467.9m USD |
Shares Outstanding | 47 474 800 |
Percentage of Shares Shorted | 5.6% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of dual-sided fusion proteins. The firm has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The firm's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.
Contact
IPO
Employees
Officers
The intrinsic value of one STTK stock under the Base Case scenario is 0.63 USD.
Compared to the current market price of 9.9 USD, Shattuck Labs Inc is Overvalued by 94%.